Literature DB >> 8100856

Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible.

G A Wallis1, B Sykes, P H Byers, C G Mathew, D Viljoen, P Beighton.   

Abstract

Most forms of osteogenesis imperfecta are caused by dominant mutations in either of the two genes, COL1A1 and COL1A2, that encode the pro alpha 1(I) and pro alpha 2(I) chains of type I collagen, respectively. However, a severe, autosomal recessive form of OI type III with a comparatively high frequency has been recognised in the black populations of southern Africa. We preformed linkage analyses in eight OI type III families using RFLPs associated with the COL1A1 and COL1A2 loci to determine whether mutations in the genes for type I collagen were responsible for this form of OI. Recombination between the OI phenotype and polymorphic markers at both loci was shown in three of the eight families investigated. The combined lod scores for the eight families were -10.6 for COL1A1 and -11.2 for COL1A2. Further, we examined the type I procollagen produced by skin fibroblast cultures derived from 15 affected and 12 unaffected subjects from the above eight families plus one further family. We found no evidence for defects in the synthesis, structure, secretion, or post-translational modification of the chains of type I procollagen produced by any of the family members. These results suggest that mutations within or near the type I collagen structural genes are not responsible for this form of OI.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100856      PMCID: PMC1016423          DOI: 10.1136/jmg.30.6.492

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  Autosomal recessive inheritance of osteogenesis imperfecta.

Authors:  F Horan; P Beighton
Journal:  Clin Genet       Date:  1975-08       Impact factor: 4.438

Review 2.  Blot hybridisation analysis of genomic DNA.

Authors:  S Vandenplas; I Wiid; A Grobler-Rabie; K Brebner; M Ricketts; G Wållis; A Bester; C Boyd; C Måthew
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

3.  Copy number of a human type I alpha 2 collagen gene.

Authors:  R Dalgleish; B C Trapnell; R G Crystal; P Tolstoshev
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

4.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.

Authors:  S B Deak; A Nicholls; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

5.  Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.

Authors:  P Tsipouras; J C Myers; F Ramirez; D J Prockop
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

6.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

7.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

8.  Isolation and characterization of a human pro alpha 2(I) collagen gene segment.

Authors:  S Tajima; J P Ting; S R Pinnell; R E Kaufman
Journal:  J Invest Dermatol       Date:  1984-03       Impact factor: 8.551

9.  Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.

Authors:  G S Barsh; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.

Authors:  A C Nicholls; G Osse; H G Schloon; H G Lenard; S Deak; J C Myers; D J Prockop; W R Weigel; P Fryer; F M Pope
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

View more
  12 in total

1.  Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.

Authors:  Wayne A Cabral; Weizhong Chang; Aileen M Barnes; MaryAnn Weis; Melissa A Scott; Sergey Leikin; Elena Makareeva; Natalia V Kuznetsova; Kenneth N Rosenbaum; Cynthia J Tifft; Dorothy I Bulas; Chahira Kozma; Peter A Smith; David R Eyre; Joan C Marini
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

2.  The human type I collagen mutation database.

Authors:  R Dalgleish
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.

Authors:  Aileen M Barnes; Weizhong Chang; Roy Morello; Wayne A Cabral; MaryAnn Weis; David R Eyre; Sergey Leikin; Elena Makareeva; Natalia Kuznetsova; Thomas E Uveges; Aarthi Ashok; Armando W Flor; John J Mulvihill; Patrick L Wilson; Usha T Sundaram; Brendan Lee; Joan C Marini
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

Review 4.  Osteogenesis imperfecta: from phenotype to genotype and back again.

Authors:  R Smith
Journal:  Int J Exp Pathol       Date:  1994-08       Impact factor: 1.925

5.  Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice.

Authors:  Michael L Sohaskey; Yebin Jiang; Jenny J Zhao; Andreas Mohr; Frank Roemer; Richard M Harland
Journal:  J Cell Biol       Date:  2010-05-03       Impact factor: 10.539

6.  Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation.

Authors:  M Raghunath; K Mackay; R Dalgleish; B Steinmann
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

7.  CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis.

Authors:  Fleur S Van Dijk; Isabel M Nesbitt; Peter G J Nikkels; Ann Dalton; Ernie M H F Bongers; Jiddeke M van de Kamp; Yvonne Hilhorst-Hofstee; Nicolette S Den Hollander; Augusta M A Lachmeijer; Carlo L Marcelis; Gita M B Tan-Sindhunata; Rick R van Rijn; Hanne Meijers-Heijboer; Jan M Cobben; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2009-06-24       Impact factor: 4.246

8.  Osteogenesis Imperfecta: A Review with Clinical Examples.

Authors:  F S van Dijk; J M Cobben; A Kariminejad; A Maugeri; P G J Nikkels; R R van Rijn; G Pals
Journal:  Mol Syndromol       Date:  2011-10-12

Review 9.  Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

Authors:  F S Van Dijk; D O Sillence
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

10.  Osteogenesis imperfecta: a case report and review of literature.

Authors:  Bo Edelu; Ik Ndu; In Asinobi; Ha Obu; Gn Adimora
Journal:  Ann Med Health Sci Res       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.